EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 -2.881
December 31, 2025 -4.495
June 30, 2025 -5.919
December 31, 2024 -3.909
June 30, 2024 6.513
December 31, 2023 5.734
June 30, 2023 -8.948
December 31, 2022 -12.20
June 30, 2022 -13.22
December 31, 2021 -17.83
June 30, 2021 -35.39
December 31, 2020 -54.01
June 30, 2020 -21.56
December 31, 2019 -17.48
June 30, 2019 -61.20
December 31, 2018 -80.43
June 30, 2018 -91.03
December 31, 2017 -83.51
June 30, 2017 -64.56
December 31, 2016 -57.36
June 30, 2016 -5.504
December 31, 2015 10.21
Date Value
June 30, 2015 -23.10
December 31, 2014 -17.44
June 30, 2014 -15.16
December 31, 2013 -16.70
June 30, 2013 -84.16
December 31, 2012 -90.80
June 30, 2012 -56.35
December 31, 2011 -85.60
June 30, 2011 -37.41
December 31, 2010 -27.83
June 30, 2010 -42.05
December 31, 2009 -65.16
June 30, 2009 -118.77
December 31, 2008 -130.69
June 30, 2008 -95.05
December 31, 2007 -74.31
June 30, 2007 -136.22
December 31, 2006 -115.97
June 30, 2006 -29.75
December 31, 2005 -24.60
June 30, 2005 -24.60

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Basilea Pharmaceutica AG 4.920
BeOne Medicines Ltd. 5.690
AC Immune SA -0.556
CRISPR Therapeutics AG -4.761
Idorsia Ltd. -1.651